myeloproliferative disorders
Showing NaN - NaN of 10
Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis Trial in Worldwide (ACE-536, Placebo)
Recruiting
- Myeloproliferative Disorders
- +4 more
- ACE-536
- Placebo
-
La Jolla, California
- +184 more
Aug 22, 2022
Thrombocytopenia, Hematologic Malignancy, Bone Marrow Aplasia Trial in Israel, Norway, United States (Thrombosomes, Liquid
Suspended
- Thrombocytopenia
- +5 more
- Thrombosomes
- Liquid Stored Platelets (LSP)
-
Duarte, California
- +5 more
Apr 21, 2022
Myelodysplastic Syndrome, Acute Myeloid Leukemia, Myeloproliferative Disorders Trial in Canada, United States (Clofarabine,
Terminated
- Myelodysplastic Syndrome
- +9 more
-
Phoenix, Arizona
- +6 more
Feb 13, 2018
Leukemia, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases Trial in Canada, United States (Allogeneic
Completed
- Leukemia
- +2 more
- Allogeneic bone marrow transplantation
- Peripheral blood stem cell transplantation
-
Birmingham, Alabama
- +44 more
Oct 24, 2017
Leukemia, Hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in Houston (drug, radiation, biological, procedure)
Terminated
- Leukemia
- +3 more
- ARA C
- +5 more
-
Houston, TexasTexas Children's Hospital
Mar 24, 2016
Myeloproliferative Disorders Trial in Houston (SB939)
Completed
- Myeloproliferative Disorders
-
Houston, TexasUT MD Anderson Cancer Center
Dec 13, 2013
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myeloproliferative Disorders Trial in Houston (Hum-195/rGel)
Completed
- Acute Myeloid Leukemia
- +3 more
-
Houston, TexasUT MD Anderson Cancer Center
Apr 1, 2013
